Senate Bill 675
2019-2020 Regular Session
An Act providing for certification of buprenorphine office-based prescribers; limiting the use of buprenorphine; and imposing powers and duties on the Department of Drug and Alcohol Programs.
Co-Sponsorship Memo
Prime Sponsor
Senator Michele Brooks
R Senate District 50
Co-Sponsors
Sen. Patrick Browne
R Senate District 16
Sen. Scott Hutchinson
R Senate District 21
Sen. Patrick Stefano
R Senate District 32
Sen. Kim Ward
R Senate District 39
Sen. Thomas Killion
R Senate District 9
Sen. Mike Folmer
R Senate District 48
Bill Status & History
Last Action: Referred to Human Services, June 18, 2019
House
S
H
| 0820 | Referred to Health & Human Services, May 28, 2019 |
| Reported as committed, June 4, 2019 | |
| First consideration, June 4, 2019 | |
| Second consideration, June 5, 2019 | |
| Re-referred to Appropriations, June 5, 2019 | |
| Re-reported as committed, June 10, 2019 | |
| Third consideration and final passage, June 17, 2019 (41-9) | |
| In the House | |
| Referred to Human Services, June 18, 2019 |
Printers Numbers
Votes
Monday, June 10, 2019
Senate APPROPRIATIONS Committee Vote
Senate APPROPRIATIONS Committee Vote - Senate Bill 675 PN0820, Re-Reported as Committed - opens in a new tab
Senate APPROPRIATIONS Committee Vote - Senate Bill 675 PN0820, Re-Reported as Committed - opens in a new tab
| 7 4 - opens in a new tab |
Tuesday, June 4, 2019 - Senate HEALTH & HUMAN SERVICES Committee Vote
|
Committee Meetings
Voting meeting on HB 730, HB 1220, SB 675 and any other business that may come before the committee.
Voting meeting on HB 730, HB 1220, SB 675 and any other business that may come before the committee.
Voting meeting on HB 386, HB 1662, SB 675 and any other business that may come before the committee.
Voting meeting on HB 386, HB 1662, SB 675 and any other business that may come before the committee.
(to consider Senate Bills No. 314, 432, 454, 569, 572, 633, 675, 695; and House Bill No. 856)
(to consider Senate Bills No. 314, 432, 454, 569, 572, 633, 675, 695; and House Bill No. 856)
Statute References
There are no statute references for this bill.
Senate Bill 675
2019-2020 Regular Session
Sponsors
BROOKS, BROWNE, HUTCHINSON, STEFANO, K. WARD, KILLION, FOLMER
Short Title
An Act providing for certification of buprenorphine office-based prescribers; limiting the use of buprenorphine; and imposing powers and duties on the Department of Drug and Alcohol Programs.
Memo Subject
Licensing Prescribers of Suboxone
Actions
| 0820 | Referred to HEALTH AND HUMAN SERVICES, May 28, 2019 |
| Reported as committed, June 4, 2019 | |
| First consideration, June 4, 2019 | |
| Second consideration, June 5, 2019 | |
| Re-referred to APPROPRIATIONS, June 5, 2019 | |
| Re-reported as committed, June 10, 2019 | |
| Third consideration and final passage, June 17, 2019 (41-9) | |
| In the House | |
| Referred to HUMAN SERVICES, June 18, 2019 |
Generated 03/22/2025 10:22 PM